| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |